Interim 2024/25 influenza vaccine effectiveness: eight European studies, September 2024 to January 2025
The 2024/25 influenza season in Europe is currently characterised by co-circulation of influenza A(H1N1)pdm09, A(H3N2) and B/Victoria viruses, with influenza A(H1N1)pdm09 predominating. Interim vaccine effectiveness (VE) estimates from eight European studies (17 countries) indicate an all-age influenza A VE of 32-53% in primary care and 33-56% in hospital settings, with some signals of lower VE by subtype and higher VE against influenza B (≥ 58% across settings). Where feasible, influenza vaccination should be encouraged and other prevention measures strengthened.
Authors
- Amanda Bolt Botnen (ORCID: https://orcid.org/0000-0003-2200-2747)
- Heather Whitaker (ORCID: https://orcid.org/0000-0001-5833-1863)
- Hanne‐Dorthe Emborg (ORCID: https://orcid.org/0000-0001-8062-0864)
- Héloïse Lucaccioni (ORCID: https://orcid.org/0000-0003-3080-9794)
- Nick Andrews (ORCID: https://orcid.org/0000-0001-9966-5093)
- Diogo FP Marques (ORCID: https://orcid.org/0000-0002-2556-0923)
- Ross McQueenie (ORCID: https://orcid.org/0000-0002-0070-6607)
- Karina Lauenborg Møller (ORCID: https://orcid.org/0000-0002-1430-5580)
- Magda Bucholc (ORCID: https://orcid.org/0000-0002-8417-1602)
- Ramona Trebbien (ORCID: https://orcid.org/0000-0003-2352-5726)
- Esther Kissling (ORCID: https://orcid.org/0000-0001-7188-8404)
- Jamie Lopez Bernal (ORCID: https://orcid.org/0000-0002-1301-5653)
- Freja Kirsebom (ORCID: https://orcid.org/0000-0003-4585-319X)
- Safraj Shahul Hameed (ORCID: https://orcid.org/0000-0001-5475-1318)
- Francisco Pozo (ORCID: https://orcid.org/0000-0003-1828-733X)
- Mark G. O’Doherty (ORCID: https://orcid.org/0000-0001-9976-258X)
- Angela MC Rose (ORCID: https://orcid.org/0000-0002-2493-8082)
- Siobhán Murphy (ORCID: https://orcid.org/0000-0001-9765-3873)
- Kimberly Marsh (ORCID: https://orcid.org/0000-0002-2721-1639)
- Simon Cottrell (ORCID: https://orcid.org/0000-0003-0645-2764)
- Mark Hamilton (ORCID: https://orcid.org/0009-0000-8806-2502)
Institutions
- Statens Serum Institut (DK)
- National Health Service Scotland (GB)
- European Council (BE)
- Instituto de Salud Carlos III (ES)
- Public Health Wales (GB)
- Public Health Scotland (GB)
- Public Health Agency (GB)
- Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (ES)
- UK Health Security Agency (GB)
Publication Details
- Journal
- Eurosurveillance
- Published
- 2025-02-20
- DOI
- https://doi.org/10.2807/1560-7917.es.2025.30.7.2500102
- Citations
- 19
- Primary Topic
- Influenza Virus Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 25.73
Funders
- European Centre for Disease Prevention and Control
- University College Dublin
- Nemzeti Kutatási Fejlesztési és Innovációs Hivatal
- Lietuvos Sveikatos Mokslų Universitetas
- Statens Serum Institut
- National Research, Development and Innovation Office